Will Zepzelca be available to European and UK patients soon? Here's what we know, and your options if you can't wait.
Medicine focus
-
April 23, 2024
-
April 16, 2024
Can givinostat be used to treat polycythemia vera? Here's what clinical trial data show.
-
April 16, 2024
When will the new nonsteroidal treatment for Duchenne be available in the EU and the UK?
-
Could Tivdak treat more than cervical cancer? Here's the latest overview of trials focusing on ovarian, head and neck cancers, and more.
-
April 02, 2024
When will European patients have access to the newest FDA-approved neuroblastoma treatment?
-
April 02, 2024
Iptacopan will soon be approved in Europe, but when will it be available to patients?
-
March 26, 2024
Zynyz(retifanlimab) may have a larger role to play in cancer treatment. Find out the latest research in renal cell carcinoma and more.
-
March 26, 2024
When will Wainua be available to patients in Europe and the UK? The latest news and all your options in the meantime.
-
March 19, 2024
Toripalimab is being studied as a treatment of NSCLC, oesophageal cancer, melanoma, and more. What does research tell us, and what does it mean for you?
-
March 19, 2024
Can Balversa be used to treat breast cancer? What we know from research, and what it means for you.
-
March 12, 2024
Toripalimab may get its EMA and MHRA approvals soon, but when will it be available to patients? All you need to know.
-
March 12, 2024
When will Tivdak be available to patients in Europe and the UK? All you need to know, and all your options to get the treatment quicker.
-
March 05, 2024
Zynyz is close to EMA approval, but it won't be immediately available everywhere in Europe. Here's how to get the treatment at your own timeline.
-
March 05, 2024
Erdafitinib may get its EMA approval in 2024, but when will it be available on the market?
-
March 05, 2024
Can tazemetostat treat bladder cancer, prostate cancer, and more? Here's the latest research.
-
March 05, 2024
Tazverik seems a long way from EMA approval. If you can't wait, here are all your options to safely get the treatment.
-
February 21, 2024
Get the latest updates on Tofersen's EMA approval timeline and discover alternative ways to access the medicine in the meantime.
-
February 13, 2024
What does Relyvrio's recent EMA rejection mean for ALS patients in Europe? All you need to know (and what you can do to get the treatment quickly)
-
February 13, 2024
When will Radicut/Radicava(edaravone) be available to ALS patients in Europe and the UK (and what to do in the meantime).
-
February 06, 2024
When is the first nasal spray for dry eyes coming to Europe (and what to do in the meantime)
-
February 06, 2024
Topical roflumilast isn't likely to be available in Europe soon. Here's what you can expect, and some solutions for the meantime.
-
January 31, 2024
How effective is adagrasib for brain metastases? The latest data, and how to access the treatment quickly.
-
January 23, 2024
When are Elahere's EMA and MHRA approvals expected, and what can patients in Europe and the UK do in the meantime.
-
January 23, 2024
When will Leqembi receive MHRA approval? And how you can access the medicine in the meantime.
-
January 15, 2024
Ryzneuta's EMA and MHRA approvals seem nowhere in sight. Here's how you can access the medicine without waiting.
-
January 15, 2024
When will capivasertib be available to breast cancer patients in Europe and the UK? Approval status, timelines, and all your options for accessing the medicine quickly.
-
January 15, 2024
Everything you need to know about nitrogacestat's approval in Europe and the UK. Including all your options to access the medicine earlier.
-
January 08, 2024
What's after Enhertu? Some of the alternatives your doctor may consider if Enhertu starts working.
-
December 12, 2023
How does Herceptin compare to Enhertu? Find out the similarities and differences between these two treatments for HER2-positive cancer.
-
December 12, 2023
What is the age limit for ruxolitinib? Find out all about the potential use of Opzelura on children.